Comparing two dialysis methods for removing toxins
Part of Immune system & allergy, Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.
This trial compares two types of dialysis—expanded hemodialysis and high-volume online hemodiafiltration—to see which removes waste products from the blood better. If you are on standard expanded hemodialysis, joining could help find the best way to clean your blood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have end-stage kidney disease and have been on dialysis for more than 3 months.
- You are currently on expanded hemodialysis three times a week for at least 1 month.
- You make very little urine (less than 100 mL per day).
- Your dialysis access can support a blood flow of at least 300 mL per minute.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of dialysis filters (medium cut-off vs. high-flux) to see if one works better for cleaning your blood. If you are already on regular dialysis, this trial may help find the best option for you.
This trial tests a special dialysis filter (Elisio HX) that removes more waste products from the blood. It aims to see if this approach improves health outcomes for people on regular in-center hemodialysis.
This trial tests whether adding a special blood-filtering device (hemoadsorption) to your regular dialysis treatment can reduce uncomfortable symptoms caused by kidney failure, like fatigue or itching. Researchers will track how you feel over time compared to standard dialysis alone.
This trial tests two types of dialysis filters (medium cut-off and high-flux) to see which one better manages mineral and bone problems common in people on hemodialysis. It may help find a way to improve bone health and mineral balance.
This trial compares two ways to prevent blood clots during a specific type of kidney dialysis called hemodiafiltration. If you have end-stage kidney disease and receive dialysis three times a week, this study may help doctors find the safest anticoagulation method for you.
This trial tests whether removing extra fluid during your regular dialysis sessions can help lower high blood pressure and reduce symptoms of fluid buildup. You'll continue your normal three-times-a-week dialysis but with adjusted fluid removal amounts.
Hear when a new Chronic Kidney Disease on Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.